Cargando…
Shrinkage of a pituitary metastasis of melanoma induced by pembrolizumab: a case report
BACKGROUND: Pituitary metastases are rare, often deriving from lung or breast cancer owing to the upper vena cava proximity. Pituitary metastases can manifest with signs and symptoms of pituitary tumors, consequent to mass effect (headache, visual impairment) and/or hormonal alterations (hyperprolac...
Autores principales: | Giuffrida, Giuseppe, Ferraù, Francesco, Alessi, Ylenia, Cannavò, Salvatore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582141/ https://www.ncbi.nlm.nih.gov/pubmed/34758866 http://dx.doi.org/10.1186/s13256-021-03150-4 |
Ejemplares similares
-
Temozolomide-Induced Shrinkage of a Pituitary Carcinoma Causing Cushing's Disease — Report of a Case and Literature Review
por: Curtò, Lorenzo, et al.
Publicado: (2010) -
Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas
por: Giuffrida, Giuseppe, et al.
Publicado: (2022) -
Multidisciplinary Management of Pituitary Apoplexy
por: Albani, Adriana, et al.
Publicado: (2016) -
Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment
por: Larsen, Frederik Uttenthal, et al.
Publicado: (2019) -
Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience
por: Giuffrida, G, et al.
Publicado: (2019)